A chemical approach to the understanding of schizophrenia

Anales des la Asociacion Quimica Argentina

Volumn 86, Issue 3-6, 1998, Pages 320-335

  Pomilio, Alicia B ^a   Vitale, Arturo A ^a   Ciprian Ollivier, Jorge ^a   Cetkovich Bakmas, Marcelo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006324599     PISSN: 03650375     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. C. D. Schteingart and A. B. Pomilio, J. Nat. Products. 47, 1046 (1984).
2. E. G. Gros, A. B. Pomilio, A. M. Seldes and G. Burton, 'Introducción al estudio de los Productos Naturales', Serie Química, Monography Nr. 30, 1985. General Secretary of the American States Organization (ASO; OEA), Programa Regional de Desarrollo Científico y Tecnológico.
3. C. A. Buschi and A. B. Pomilio, Phytochemistry, 26, 863 (1987).
4. A.B. Pomilio, R.D. Rofi, M.P. Gambino, C.A. Mazzini and T. Debenedetti de Langenheim, Toxicon, 27, 1251 (1989).
5. A.B. Pomilio, An. Asoc. Quím. Argent. 80, 241 (1992).
6. V.N. Adonaylo, A. Stahl, C.O. Canellas, A.B. Pomilio and A.A. Vitale, J. Labelled Compnds. Radiopharm. 23, 443 (1993).
7. E.G. Gros, N.S. Nudelman, A.M. Seldes, A.B. Pomilio, J.C. Oberti, H.B. Arzeno, Z.M. Marcote, H.M. Garraffo, C.A. Russo, M.E.J. Coronel, M.M. Rivero, C.G. Arabehety and R. Baez Barreto, An. Asoc. Quím. Argent. 65, 187 (1977).
8. A. B. Pomilio, Acta Bioquím. Clín. Latinoamer., 29, 3 (1995).
9. A. A. Vitale, A. Acher and A.B. Pomilio, J. Ethnopharmacol., 49, 81 (1995).
10. A.C. Casabuono and A.B. Pomilio, J. Ethnopharmacol. 57, 1 (1997).
11. A.B. Pomilio and E.A. Jares, Int. J. Pharmacog., 35, 1 (1997).
12. A.A. Vitale, M. A. Calvino, C. C. Ferrari, A. Stahl and A.B. Pomilio. J. Labelled Compnds. Radiopharm., 36, 509 (1995).
13. A.B. Pomilio and A.A. Vitale, Conferences about: 'Indolic Markers', Jornada de la Asociación Argentina de Psiquiatría Biológica, II Congreso Internacional de la Asociación Argentina de Psiquiatras, Buenos Aires, 25-28 October 1995.
14. A.B. Pomilio, B. Ellmann, K. Künstler, G. Schilling and K. Weinges, Justus Liebigs Ann. Chem., 588 (1977).
15. A.B. Pomilio, O. Müller, G. Schilling and K. Weinges, Justus Liebigs Ann. Chem., 597 (1977).
16. M. G. Barolli and A. B. Pomilio, J. Labelled Compnds. Radiopharm., 39, 927 (1997).
17. H. Viola, C. Wolfman, M. Levi de Stein, C. Wasowski, A. Pomilio, A.C. Paladini and J.H. Medina, Naturally - Occurring Anxiolytics. II. Biochemical and Pharmacological Characterization of Flavonolds. (Abstract 39). VII Reunión Nacional de la Sociedad Argentina de Neuroquímica (SAN). 15-18 November 1992, Córdoba, Argentina.
18. M. Marder, H. Viola, C. Wolfman, C. Wasowski, M. Levi de Stein, A. Pomilio, J.H. Medina and A.C. Paladini. Ligands for benzodiazepine receptors from Ginkgo biloba L., VIII Reunión Nacional de la Sociedad Argentina de Neuroquímica (SAN), 27-29 October 1993, Villa Giardino, Córdoba.
19. A.C. Paladini, C. Wasowski, M. Marder, C. Wolfman, M. Levi de Stein, H. Viola and A. B. Pomilio. On the search for a natural 'valium'. Expociencia'93. Investigaciones en curso en UBA. Facultad de Ingeniería (UBA), 17-23 November 1993.
20. M. Marder, C. Wasowski, H. Viola, C. Wolfman, A. Pomilio, P. G. Waterman, J. Medina and A.C. Paladini. Synthetic Bromoflavones with high affinity for the central BDZ receptor. (Abstract 122). IX Reunión Nacional de la Sociedad Argentina de Neuroquímica (SAN). XXX Sociedad Argentina de Investigadores en Bioquímica (SAIB). V AABD. 26-29 October 1994, Iguazú, Misiones.
21. C. O. Cañellas, M.G. Argüelles. G.A. Rutty Solá, A.A. Vitale, A.B. Pomilio, M.E. Viaggi, J.J. Martínez Sampere, R. Dezi, O. Iodice, J.M. Affanni, V. Soroa, A. Fraga de Suares and O. Degrossi, Rev. Esp. Med. Nuclear, 9, 57 (1990).
22. M.G. Argüelles, G.A. Rutty Solá, C.O. Canellas, M.E. Viaggi, A.A. Vitale, A.B. Pomilio, R. Dezi, O. Iodice, J.M. Affanni, V. Soroa, A. Fraga de Suares and O. Degrossi, Rev. Argent. Nuclear, 4, 42 (1990).
23. M.G. Argüelles. G.A. Rutty Solá, C.O. Cañellas, M.E. Viaggi, A.A. Vitale, A.B. Pomilio, R. Dezi, O. Iodice, J.M. Affanni, V. Soroa, A. Fraga de Suares and O. Degrossi. Rev. Argent. Nuclear, 4, 53 (1990).
24. M. G. Argüelles, G. A. Rutty Solá, C. O. Cañellas, M. E. Viaggi, A.A. Vitale, A. B. Pomilio, R. Dezi, O. Iodice, J. M. Affani, V. Soroa, A. Fraga de Suares, O. Degrossi and J. J. Martinez Sampere, HM-PAO-Tc-99m and other lipophilic agents for brain visualization. XI Congress of the Latinamerican Association of the Societies of Biology and Nuclear Medicine, ALASBIMN, Santiago, Chile, 1-11 October 1989.
25. C.O. Cañellas, R. Dezi, O. Iodice, J.M. Affanni, A.B. Pomilio, A.A. Vitale and J.J. Martínez Sampere. "An animal model for radiopharmaceutical research (Didelphis albiventris) in HM-PAO-Tc-99m use." The Seventh International Symposium on Radiopharmacology, Boston, Massachusetts, 3-6 June 1991.
26. J. Ciprian-Ollivier, M. Cetkovich-Bakmas, A. B. Pomilio and A. A. Vitale, J. Neural Transm., 1998, submitted.
27. J. Ciprian-Ollivier, M. G. Cetkovich-Bakmas, O. Boullosa, A. López-Mato, E. Gómez, A. Vitale and A. Pomilio. 'Ayahoasca': an experimental psychosis that mirrors the transmethylation hypothesis of perceptual alterations in schizophrenia. (Abstract 87, pp. 205-206). Critical Issues in the Treatment of Schizophrenia. International Academy for Biomedical and Drug Research. Palazzo dei Congressi, Florencia, Italia, 10-12 March 1995.
28. A.B. Pomilio, 'Structural Study of Phytocompounds with Cytotoxic and Neurochemical Activity'. (Plenary Conference; Abstract 6) The Eighth Latinamerican Symposium of Pharmacobotany. Il Reunión de la Sociedad Latinoamericana de Fitoquímica. Montevideo, Uruguay, 20-23 March 1996.
29. A. B. Pomilio and A. A. Vitale, Phytochemical Analysis, in press.
30. A. B. Pomilio, A. A. Vitale, J. Ciprian-Ollivier, M. Cetkovich-Bakmas, R. Gómez and G. Vázquez, J. Ethnopharmacol., in press (1998).
31. V. Deulofeu, Ciencia e Investigación 23, 95 (1967).
32. V. Deulofeu, Chemical compounds isolated from Banisteriopsis and related species. In: Ethnopharmacologic Search for Psychoactive Drugs. D. H. Efron, B. Holmstedt and N. S. (Eds.). U.S. Department of Health, Education, and Welfare, Public Health Service Publication No. 1645, Washington D.C., pp. 393-402 (1967).
33. L. Rivier and J.-E. Lindgren, Economic Botany 29, 101 (1972).
34. D. J. McKenna, G. H. N. Towers and F. Abbott, J. Ethnopharmacol. 10, 195 (1984).
35. D. J. McKenna and G. H. N. Towers, J. Psychoactive Drugs 17, 35 (1985).
36. R. E. Schultes, J. Ethnopharmacol. 14, 105 (1985).
37. C. Aranha, G. Travaini and M. A. Correa, Aspectos botánicos e taxonómicos das plantas Banisteriopsis sp. e Psychotria sp. 1st Congresso em Saude, Centro de Estudos Medicos, União do Vegetal, São Paulo, Brasil, 30 May-2 June (1991).
38. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Chairperson: Allen Frances, M.D. (Chair, Task Force on DSM-IV) and Michael B. First, M. D. (Editor, DSM-IV Text and Criteria), 4th Edition (DSM-IV), Washington, D.C., 886 pp. (1994).
39. D. R. Weinberger, Neurodevelopmental Perspectives on Schizophrenia, Chapter 98, pp. 1171-1183, in: Psychopharmacology: The fourth Generation of Progress, an Official Publication of the American College of Neuropsychopharmacology, Editors-in-Chief: F. E. Bloom and D. J. Kupfer, Raven Press, New York (1995).
40. B. Garland Bunney, W. E. Bunney, Jr. and A. Carlsson, Schizophrenia and Glutamate, Chapter 101, pp. 1205-1214, in: Psychopharmacology: The fourth Generation of Progress, an Official Publication of the American College of Neuropsychopharmacology, Editors-in-Chief: Floyd E. Bloom and David J. Kupfer, Raven Press, New York (1995).
41. B. L Roth and H. Y. Meltzer, The Role of Serotonin in Schizophrenia, Chapter 102, pp. 1215-1227, in: Psychopharmacology: The fourth Generation of Progress, an Official Publication of the American College of Neuropsychopharmacology, Editors-in-Chief: Floyd E. Bloom and David J. Kupfer, Raven Press, New York (1995).
42. R. S. Kahn and K. L. Davis, New Developments in Dopamine and Schizophrenia, Chapter 100, pp. 1193-1203, in: Psychopharmacology: The fourth Generation of Progress, an Official Publication of the American College of Neuropsychopharmacology, Editors-in-Chief: Floyd E. Bloom and David J. Kupfer, Raven Press, New York (1995).
43. J. F. Greden and R. Tandon, Eds., Negative schizophrenic symptoms: Pathophysiology and clinical implications, American Psychiatric Press Inc., Washington (1991).
44. A. Carlsson, The dopamine theory revisited. In: Schizophrenia, S. Hirsch and D. R. Weinberger (Eds.), Blackwell Science, Oxford, U.K., pp 379-400 (1995).
45. A. Carlsson, Interaction between dopaminergic and serotoninergic systems. Proceedings of the 18th Collegium Neuro-Psychopharmacologicum Internationale Congress. Clinical Neuropharm., 15, Suppl. 1-A, 616-617, Raven Press, New York (1992).
46. H. Osmond and J. Smythies, J. Ment. Sci. 98, 309 (1952).
47. R. J. Wyatt and J. J. Gillin, Psychiatric Annals 6, 35 (1976).
48. J. Ciprian-Olllivier, M. G. Cetkovich-Bakmas and O. Boullosa, Abnormally methylated compounds in mental illness. In: Biological Psychiatry 1985. C. Shagass et al., Editors. Elsevier Publishing Co., New York, pp. 243-245 (1986).
49. J. Ciprian-Ollivier and M. G. Cetkovich-Bakmas, Schizophrenia Res. 28, 257 (1997).
50. J. Ciprian-Ollivier, M. G. Cetkovich-Bakmas, O. Boullosa and A. López-Mato, Psicosis esquizofrénicas. Teoría de la transmetilación patológica. In: Psiquiatría Biológica. Fundamentos y Aplicación Clínica. J. Ciprian-Ollivier, Editor. Ed. Científica Interamericana, Buenos Aires, pp. 75-87 (1988).
51. J. Ciprian-Ollivier, Delusional status and abnormally methylated compounds. In: Biological Psychiatry. G. Racagni, N. Brunello and T. Fukuda, Editors. Proceedings of the 5th. World Congress of Biological Psychiatry. Florence, 9-14 June. Excerpta Medica, Amsterdam, pp. 627-629 (1991).
52. B. A. Davis, P. A. Yu and H. Carlsson, Psychiatry Research 6, 97 (1982).
53. J. A. Sintas and A. A. Vitale, J. Labelled Compnds. Radiopharm. 39, 677 (1997).
54. A. B. Pomilio, Acta Bioquím. Clín. Latinoamer., 28, 527 (1994).
55. A. A. Vitale, M. A. Calvino, C. Ferrari, A. B. Pomilio, J. Ciprian-Ollivier and M. Cetkovich-Bakmas, Acta Bioquím. Clín. Latinoamer., 29, 37 (1995).
56. A. A. Vitale, C. C. Ferrari, H. Aldana and J. M. Affanni, J. Chromatogr. Biomed. Appl., 681, 381 (1996).
57. Diagnostic Products Corporation (CA, USA) Cortisol Double Antibody, Protocol D563, December 30, pp. 1-13 (1985).
58. H. Kelm, The Hoffer-Osmond Diagnostic Test. In: D. Hawkins and L. Pauling (Eds.), Orthomolecular Psychiatry: Treatment of Schizophrenia. W.H. Freeman, San Francisco, pp 327-341 (1970).
59. R. B. Silverman, Acc. Chem. Res. 28, 335 (1995).
60. R. B. Yamasaki and R. B. Silverman, Biochemistry 254, 6543 (1985).
61. J. Knoll, Med. Res. Rev. 12, 505 (1992).
62. U. K. Rinne, J. Neural Transm. 25 (Suppl.), 149 (1984).
63. R. J. Strassman, C. R. Qualls, E. Uhlenhuth and R. Kellner, Arch. Gen. Psychiatry 51, 98 (1994).
64. B. Costall and R. J. Naylor, A typical neuroleptic agents interact at the 5-HT2A/2C receptors to reduce anxiety-like responding. Abstracts of the Third IUPHAR Satellite Meeting on Serotonin, Chicago, Ill., July 30-August3, p. 65 (1994).
65. S. Szára, Experientia 12, 411 (1956).
66. H. Tanimukai, R. Ginther, J. Spaide, J. R. Bueno and H. E. Himwich, Br. J. Psychiatry 117, 421 (1970).
67. S. A. Checkley, R. M. Murray, M. C. Oon, R. Rodnight and J. L. Birley, Br. J. Psychiatry 137, 236 (1980).